Yearly Archives: 2024


GWAS Improved BP Polygenic Risk Scores

A single-stage common-variant genome-wide association study (GWAS) of blood pressure (BP) in European-ancestry adults improved BP polygenic risk scores (PRS) and provided additional insights into the genetic contribution of BP. The study identified 113 novel loci, reporting a total of 2,103 independent genetic signals in 1,028,980 European individuals from the […]


MAD On Par to CPAP for Reducing BP

A randomized, non-inferiority trial in Singapore showed that mandibular advancement device (MAD) was non-inferior to continuous positive airway pressure (CPAP) for reducing 24-hour mean arterial blood pressure (BP) in patients with high BP and obstructive sleep apnea (OSA). The trial randomized 220 participants with moderate-to-severe OSA (apnea–hypopnea index AHI ≥15 […]


HR Variation and Common Clinical Correlations

A Swedish population-based study provided reference ranges of ambulatory heart rate (HR) in a middle-aged population and suggested that the wide range of interindividual differences in HR largely independent of common clinical risk factors for cardiovascular diseases. The study included 5809 atrial fibrillation-free individuals, aged 50–65 years, with a healthy […]


A New ECG Criterion for LBBB

A time to notch in lead I longer than 75 milliseconds has been proposed as a new ECG criterion for left bundle branch block (LBBB). The derivation cohort was from a prospective study of patients undergoing electrophysiological study from March 2016 through November 2019 and a validation cohort was assembled […]


Prevailing Perspective of Processed/Red Meat and CAD/T2D Challenged

A Mendelian randomization (MR) analysis did not find sufficient evidence to support a causal relationship between red/processed meat consumption and cardiovascular disease (CAD), hypertension, stroke, and type 2 diabetes (T2D). The analysis used data of publicly published genome-wide association studies. The inverse-variance weighted analyses revealed no causal association between the […]


Concomitant SSRIs and OACs Use Linked to Higher Bleeding Risk

A UK nested case-control study suggested that concomitant use of selective serotonin reuptake inhibitors (SSRIs) and oral anticoagulants (OACs) was associated with bleeding risk and should be closely monitored, particularly within the initial months of treatment. Between January 1998, and March 2021, 42 190 atrial fibrillation (AF) patients with major bleeding […]